Pharmacoeconomic Analysis of First Line Meropenem Versus Standard Antibiotic Treatment in Seriously Infected Secondary Nosocomial Sepsis Syndrome Patients. An Open, Randomized Multi-center Study.
Phase of Trial: Phase IV
Latest Information Update: 25 Jan 2011
At a glance
- Drugs Antibacterials; Meropenem
- Indications Bacterial infections; Systemic inflammatory response syndrome
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 11 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 30 Mar 2006 New trial record.